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Abstract
 
Cutaneous mast cell responses to physical (thermal, mechanical, or osmotic) stimuli underlie
the pathology of physical urticarias. In vitro experiments suggest that mast cells respond directly
to these stimuli, implying that a signaling mechanism couples functional responses to physical
inputs in mast cells. We asked whether transient receptor potential (vanilloid) (TRPV) cation
channels were present and functionally coupled to signaling pathways in mast cells, since ex-
pression of this channel subfamily confers sensitivity to thermal, osmotic, and pressure inputs.
Transcripts for a range of TRPVs were detected in mast cells, and we report the expression,
surface localization, and oligomerization of TRPV2 protein subunits in these cells. We describe
the functional coupling of TRPV2 protein to calcium fluxes and proinflammatory degranula-
tion events in mast cells. In addition, we describe a novel protein kinase A (PKA)–dependent
signaling module, containing PKA and a putative A kinase adapter protein, Acyl CoA binding
domain protein (ACBD)3, that interacts with TRPV2 in mast cells. We propose that regulated
phosphorylation by PKA may be a common pathway for TRPV modulation.
Key words: calcium channels • inﬂammation • physical urticaria • transient receptor potential • 
vanilloid receptor
 
Introduction
 
Mast cells respond to multiple stimuli, including immuno-
logical inputs, polybasic secretagogues, and physical cues
(1–5). Direct responsiveness to physical (thermal, osmotic,
and mechanical perturbation) stimuli has been described for
mast cells in vitro and in vivo (1, 3, 6–8). Mast cell responses
to these physical stimuli are causative in various urticarias
that derive from inappropriate activation of cutaneous mast
cells (1, 9–11). Physical urticarias (PU) involve wheal-flare
reactions that follow brief exposure to applied cold, heat,
pressure, or light in the UVA and short-wave visible ranges
(9, 12–14). These stimuli elicit release of histamine, serotonin,
and other inflammatory mediators from cutaneous mast
cells, causing an inflammatory reaction that is characterized
by erythema, edema, and pruritis (9, 14). PU symptoms
respond to H1-type antihistamines (9, 15). PU can be spo-
radic or may be associated with chronic (often idiopathic)
urticarial disease (16). In contrast to acute allergic inflamma-
tions, an IgE–Fc
 
 
 
RI–mediated mechanism is not widely
postulated for the PU, although this may be an important
component of chronic urticarial responses (16). In the absence
of a clear IgE dependence for the induction of PU, it
would seem important to identify a signaling mechanism
that can transduce acute physical stimuli into signals that are
necessary and sufficient to induce mast cell activation.
Cation channels of the transient receptor potential (va-
nilloid) (TRPV) family respond to various environmental
inputs across both physiological and pathophysiological
ranges. Six channels have been defined on the basis of sim-
ilarity to the prototypical vanilloid receptor (TRPV1, VR-1)
(17–20). TRPV1 was expression cloned by virtue of its
ability to confer responses to the nociomimetic lipid capsaicin
upon an epithelial cell line and is activated after exposure to
pathophysiological temperatures (
 
 
 
42
 
 
 
C) (18, 19). TRPV2
has a higher threshold than TRPV1 for heat activation
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(
 
 
 
52
 
 
 
C) and has no known similar sensitizing agents (17,
21). TRPV3 responds to warm temperatures (31–35
 
 
 
C)
and is sensitized by prior temperature elevation (17, 22–
24). Responsiveness to physiological temperatures (24–
33
 
 
 
C), hypo-osmolarity, and mechanical pressure, or shear
stress, have been described for TRPV4 (17, 25–27).
The expression pattern of TRPV2, 3, and 4 apparently
extends beyond sensory contexts, since TRPV2 transcripts
have been noted in peripheral tissues (including compo-
nents of the immune system) and TRPV3/4 conductances
have been described in epithelia and keratinocytes (17).
TRPV2 may be involved in initiating responses to noxious
temperatures in nonsensory cell types. Alternately, distinct
activation mechanisms for TRPV2 may exist in these pe-
ripheral tissue contexts. Interestingly, a signaling pathway
that is initiated by IGF-1 or a neuropeptide receptor can
cause activation of a murine TRPV2 homologue (28–30).
We can also postulate the existence of a sensitizing mecha-
nism for peripheral TRPV2, where a signaling event causes a
decrease in the threshold temperature of the channel, bring-
ing it into the physiological range. Such a mechanism exists
for TRPV1, which gates at near physiological temperatures
after cytosolic acidification or ethanol exposure (18, 31). A
PKA pathway has also been proposed to regulate sensitization
of TRPV1, although the components of this signaling mod-
ule are unknown (32, 33). To date, a similar signaling module
has not been shown to associate with or regulate TRPV2.
TRPVs confer environmental-sensing properties upon
neurons and nonsensory cell types. Via TRPVs, this sensing
may be coupled to calcium signals. In the current study, we
hypothesized that expression of TRPVs in mast cells could
confer direct sensitivity to the types of physical stimuli that
activate mast cells during PU. We find various TRPV tran-
scripts in transformed and primary mast cells. The expres-
sion and oligomerization of TRPV2 protein was confirmed
in mast cells, and our data suggest that exposure to TRPV2
threshold temperatures couples to calcium entry and spe-
cific proinflammatory events. We describe a novel regula-
tory signaling module for TRPV2. TRPV2 apparently par-
ticipates in a signaling module that comprises PKA and an
adaptor protein with A kinase adapter protein (AKAP)-like
properties. A PKA regulatory (PKAR) subunit binding
protein, Acyl CoA binding domain protein (ACBD)3, is
suggested as this adaptor that links TRPV2 and PKA. In
summary, this study identifies a novel expression context,
functional linkage, and regulatory signaling module for
TRPV2. We conclude that TRPVs may transduce physical
stimuli in mast cells, in parallel with TRPV expression in
the sensory neurons with which dermal mast cells are asso-
ciated. Therefore, TRPVs are potential targets for inter-
vention in pathologies such as PU.
 
Materials and Methods
 
Cell Culture.
 
RBL2H3 cells and HEK293 stably transfected
with pcDNA6TR (Invitrogen) were maintained in DMEM/10%
fetal bovine serum/2 mM glutamine in humidified 5% CO
 
2
 
 at
37
 
 
 
C. For production of TRexHEK293 cells with inducible ex-
pression of TRPV2, parental cells were electroporated with the
rat TRPV2 cDNA in pcDNA4TO. Clonal cell lines were se-
lected by limiting dilution in 400 
 
 
 
g/ml zeocin (Invitrogen).
TRPV2 expression was induced using 1 
 
 
 
g/ml tetracycline for
16 h at 37
 
 
 
C.
 
Antibodies and Reagents.
 
Rat TRPV2 cDNA was a gift from
Dr. David Julius (University of California, San Francisco, San Fran-
cisco, CA). Rabbit polyclonal anti-TRPV2 was from Calbio-
chem. Goat polyclonal anti-PKAR subunit was from Chemicon.
Rabbit polyclonal anti-ACBD3 (34) was a gift from Dr. V. Papa-
dopoulos (Georgetown University, Washington DC). Anti–
phospho PKA substrate motif antibody was from Cell Signaling
Technology. Anti-FLAG was from Sigma-Aldrich. HRP-conju-
gated secondary antibodies were from Amersham Biosciences.
Hoechst and Alexa fluorophore–conjugated IgGs were from Mo-
lecular Probes. Lipidated, cell permeant, HT31 peptide (35) was
from Promega.
 
RT-PCR and Electrophoresis.
 
RT-PCR on RBL2H3 poly A
 
 
 
mRNA was performed using the following primers: (5
 
 
 
-3
 
 
 
, for-
ward/back): TRPV1, cggctttttgggaagggtg/tgtctctgggtctttgaactcgc;
TRPV2, gaacctcaacttcataaagagacctcc/ccttggtagaactcatcggtgc; TRPV3,
tcaggatgatgtgacagagaccc/cagcgaaggcaagcagaatc; TRPV4, tggacgga-
ctgctctcctacttg/tcatccttgggctggaagaac; TRPV5, ccatcctccagcaaaaac-
tactacag/gaaacgcattaggtctccaaaaatc; and TRPV6, cctttgctgcctgtgtg-
ggtag/ttggtggtaacaataagttccagtagag.
 
Northern Blots.
 
Multiple tissue and immune system Northern
blots were purchased from CLONTECH Laboratories, Inc. and
probed according to the manufacturer’s instructions. Multiple cell
line Northern blots were produced using 1 
 
 
 
g/lane poly A
 
 
 
mRNA. The TRPV2 cDNA probe comprised a 353-bp HincII-
NotI fragment.
 
Immunoprecipitation and Western Blot.
 
Cells were pelleted
(2000 
 
g
 
, 2 min) and washed once in ice cold PBS. Approximately
10
 
7
 
 cells were lysed (in ice for 30 min) in 350 
 
 
 
l of lysis buffer (50
mM Hepes, pH 7.4, 75 mM NaCl, 20 mM NaF, 10 mM iodoac-
etamide, 0.5% [wt/vol] Triton X-100, 1 mM PMSF, 500 
 
 
 
g/ml
aprotinin, 1.0 mg/ml leupeptin, and 2.0 mg/ml chymostatin).
Lysates were clarified (10,000 
 
g
 
, 5 min). For preparation of total
protein, lysates were acetone precipitated. For immunoprecipita-
tion, supernatants were tumbled (at 4
 
 
 
C for 2 h) with the indi-
cated antibody, covalently coupled (dimethylpimelidate/ethanol-
amine) to protein G–Sepharose.
Samples were boiled in Laemmli buffer, resolved by SDS-
PAGE, and electrotransferred to PVDF. Membranes were
blocked using 5% nonfat milk or BSA (1 h at RT). Primary anti-
bodies were incubated with membrane for 16 h at 4
 
 
 
C. Develop-
ing antibodies were diluted to 0.1 
 
 
 
g/ml and incubated with
membranes for 45 min. For cell surface biotinylation, intact cells
were incubated (30 min at RT) with 1 mg/ml sulfo-NHS-biotin
(Pierce Chemical Co.) in PBS, pH 8.0. Cells were washed four
times in PBS/25 mM NH
 
4
 
Cl and then lysed/immunoprecipi-
tated as above in the presence of 25 mM NH
 
4
 
Cl.
 
Blue-Native Electrophoresis.
 
Blue-Native (BN)–PAGE was
adapted from Schagger and Von Jagow (36) and Schamel et al.
(37). Gradient gels (6–20%) were electrophoresed in BN sample
buffer (5% [wt/vol] Coomassie-G250, 100 mM Bis-Tris, pH 7.0,
500 mM 6-aminocaproic acid). Anode buffer was 50 mM Bis-Tris,
pH 7.0. Cathode buffer was 50 mM tricine/15 mM Bis-Tris, pH
7.0. For the first 90 min of resolving time (100 V/1 h then 600 V/
16 h), Coomassie-G250 was included in the cathode buffer at
0.02% (wt/vol). Gels were electrotransferred and Western blotted.
 
Immunofluorescence.
 
Cells were fixed and permeabilized on
glass coverslips (4% paraformaldehyde followed by 0.4% Triton 
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X-100 for 20 min at RT). After blocking (0.7% fish skin gelatin),
coverslips were sequentially incubated with primary and second-
ary antibodies and the indicated stains. Imaging was performed
with an Olympus IX70 fluorescence inverted microscope with
quadruple dichroic filter block and excitation filter set 88000
(Chroma) connected to an F-view monochrome CCD camera.
 
Phosphorylation Assays.
 
For metabolic labeling with 
 
32
 
P
 
i
 
,
RBL2H3 were incubated for 3 h in phosphate-free DMEM be-
fore addition of 250 
 
 
 
Ci/ml 
 
32
 
P orthophosphate for 4 h. Cells
were harvested and then lysed as described in the Immunoprecip-
itation and Western Blot section. Immunoprecipitation and SDS-
PAGE were performed as described in the Immunoprecipitation
and Western Blot section, and the resulting gel was autoradio-
graphed. For in vitro phosphorylation assays, dried immunocom-
plexes were resuspended in a buffer containing 50 mM Tris, pH
7.4, 1 mM EDTA, 12 mM MgCl
 
2
 
, and 250 
 
 
 
M ATP. Additional
components were added as indicated, (10 mM cAMP, 10 mM
cGMP, 5 
 
 
 
Ci 
 
32
 
P
 
 
 
ATP, 1 U/
 
 
 
l PKA or protein kinase G [PKG]
[Promega]). Reactions were incubated at 30
 
 
 
C for 30 min,
stopped by addition of reducing sample buffer, and then resolved
by SDS-PAGE.
 
Fura-2 Calcium Assay.
 
RBL2H3 were loaded with 4 
 
 
 
M
Fura-2 a.m. (Molecular Probes) in Ringer buffer with 1 mM
CaCl
 
2
 
, 
 
 
 
330 mOsm, for 45 min at 37
 
 
 
C. After washing, bulk as-
say of calcium flux was performed as described (38). As a positive
control, cells were stimulated with thapsigargin (1 
 
 
 
M) or iono-
mycin (500 nM) in the absence and presence of external calcium
(not depicted).
 
Serotonin Release Assay.
 
Adherent RBL2H3 (2 
 
 
 
 10
 
4
 
 cells/
cm
 
2
 
) were incubated with 1 
 
 
 
Ci/ml 
 
3
 
H hydroxytryptamine
(New England Nuclear) for 16 h at 37
 
 
 
C. Monolayers were then
washed once in Tyrode’s buffer at 37
 
 
 
C, and cells were incu-
bated with the indicated stimuli or vehicle in 250 
 
 
 
l/cm
 
2
 
 Ty-
rodes buffer for 45 min at 37
 
 
 
C. Reactions were stopped by
quenching in ice cold PBS and counted in liquid scintillation
cocktail.
 
Results
 
TRPV Expression in Mast Cells.
 
Mast cells mount in-
tense responses to environmental cues, including thermal,
osmotic, and mechanical inputs (1, 3, 11). The correlation
between these stimuli and the known activation mecha-
nisms for TRPV channels is striking (17). We hypothesized
that TRPVs may mediate calcium entry into mast cells in
response to certain classes of physical stimulation. We ana-
lyzed TRPV mRNA representation in the model mast cell
line RBL2H3. RT-PCR reactions were performed using
primer pairs designed to selectively amplify each TRPV,
and TRPM7, which is an abundant conductance in
RBL2H3 (39). Fig. 1 A shows that transcripts for TRPV1,
2, 4, 6, and TRPM7 may be detected in RBL2H3 cells by
RT-PCR. The identity of the PCR products was con-
firmed by excision, purification, and sequencing.
TRPV2 transcripts are present in various tissues and the
rodent mast cell lines P815 and RBL2H3 (Fig. 1 B). Using
quantitative PCR, we assessed that murine BM-derived
mast cells (BMMCs) and RBL2H3 contained TRPV2
transcripts at a resting level of 
 
 
 
10-12 pg per ng poly A
 
 
 
mRNA (
 
n 
 
  
 
3). TRPV2 transcripts could also be detected
in primary human cord blood–derived mast cells and hu-
man basophils (unpublished data). TRPV2 transcript levels
in cord blood–derived mast cells are comparable with that
found in primary human neutrophils, a previously defined
context for TRPV2 (40).
 
TRPV2 Is Present in Mast Cells as a Cell Surface Oligomer
with Tetrameric Stoichiometry.
 
We sought to confirm that
TRPV2 protein is present and that TRPV2 exists in mast
cells as a functional, cell surface, channel oligomer. Fig. 2
A shows that anti-TRPV2 recognizes a 
 
 
 
90-kD protein
doublet in lysates that were isolated from primary murine
Figure 1. (A) RT-PCR analysis
of TRPV expression in RBL2H3.
Poly A  mRNA was prepared
from RBL2H3 mast cells. RT-
PCR using specific primers for
TRPM7 and TRPV1-6. RT-
PCR was performed as described
in Materials and Methods. After
agarose gel electrophoresis (left),
specific products were excised
from the gel and sequenced.
BLAST analysis of sequence files
was used to confirm the specificity
of the PCR product (right). Re-
sults are representative of two sep-
arate primers pairs per transcript.
(B) Northern blot analysis of
TRPV2 expression. Multiple tis-
sue Northern blots (left and mid-
dle; CLONTECH Laboratories,
Inc.) were probed with a 32P-
labeled  cDNA fragment corre-
sponding to a 353-bp fragment
(HincII–NotI) derived from rat
TRPV2. Strong hybridization of
a single band of  2.8 kb was vis-
ible after 16-h exposure to storage
phosphor screens. 
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Figure 2.
 
(A) Presence of TRPV2 protein in transformed and primary mast cells. Triton X-100 lysates were prepared from 5 
 
 
 
 10
 
6
 
 murine BMMC
(left) or 2 
 
 
 
 10
 
7
 
 RBL2H3 or P815 cells (right). Total protein (BMMC) or anti-TRPV2 immunoprecipitates (RBL2H3, P815) were prepared as described
in Materials and Methods. Proteins were resolved by 10% SDS-PAGE. TRPV2 content of the immunocomplexes was visualized via an anti-TRPV2
Western blot. (B) Incubation with TRPV2 epitope peptide diminishes the presence of the 90-kD putative TRPV2 doublet in anti-TRPV2 immuno-
complexes. Triton X-100 lysates were prepared from 2 
 
 
 
 10
 
7
 
 RBL2H3. Lysates were immunoprecipitated with 10 
 
 
 
g anti-TRPV2 or with rabbit IgGs
in the absence or presence of 10 
 
 
 
g/ml anti-TRPV2 epitope peptide (KMSASEEDHLPLQVLQSP). Band at 55 kD corresponds to antibody heavy
chain. (C) Anti-TRPV2 and anti-FLAG antibodies reciprocally immunoprecipitate FLAG-TRPV2. TRexTRPV2 cells, with FLAG-TRPV2 expression
under the control of a tetracycline-sensitive transcriptional repressor, were constructed as described in Materials and Methods. TRexTRPV2 were
exposed to vehicle or 1 
 
 
 
g/ml tetracycline for 16 h at 37
 
 
 
C to induce expression of FLAG-TRPV2. Triton X-100 lysates from 10
 
7
 
 TRexTRPV2 cells 
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BMMCs. Moreover, a similar protein doublet may be im-
munoprecipitated from RBL2H3 and P815 mast cells us-
ing this anti-TRPV2. Migration analysis (not depicted)
suggests that these two protein species have molecular
weights of 94 and 87 kD. The presence of two mobility
forms of TRPV2 may indicate differential posttranslational
modification, including glycosylation or phosphorylation
(see Fig. 4). Specificity of the anti-TRPV2 is evidenced by
the two experiments shown in Fig. 2, B and C. Fig. 2 B
demonstrates that preincubation with the antigenic pep-
tide ablates immunoprecipitation of the TRPV2 doublet.
Fig. 2 C shows that the anti-TRPV2 immunoprecipitates
a protein doublet from a TRexHEK cell line that ex-
presses a FLAG epitope-tagged version of TRPV2, under
the control of a tetracycline-sensitive transcriptional re-
pressor. The same doublet may be precipitated via either
the NH
 
2
 
-terminal FLAG tag or the COOH-terminal anti-
TRPV2 epitope.
TRP channels form functional tetramers in the plasma
membrane (41). Since we are describing a novel expression
context for TRPV2, we asked if the channel forms oligo-
mers in mast cells and we assessed the subcellular localiza-
tion of TRPV2. We, and others, have noted apparently de-
tergent-resistant complexes of TRP channels, including
TRPV2, even under SDS-PAGE conditions (42). It is un-
clear if these complexes represent physiological oligomers,
and they cannot be sized accurately by conventional SDS-
PAGE. Therefore, we employed a blue-native electro-
phoresis system to analyze the oligomerization of TRPV2.
Blue-native electrophoresis uses aminocaproic acid and
Coomassie dye to solubilize and charge-shift large mem-
brane protein complexes, respectively (36, 37). Native
TRPV2 complexes purified from RBL2H3 (Fig. 2 D) mi-
grate in this system at a molecular weight (375 kD) that is
consistent with the tetrameric stoichiometry that has been
demonstrated for TRPVs 1, 5, and 6 (42–44). Similar oligo-
mers are present in the TRexTRPV2 cells, although an
abundant monomeric population also appears as a presum-
able result of overexpression (unpublished data).
We were able to surface biotinylate TRPV2 in a resting
population of RBL2H3 (Fig. 2 E). To assess the proportion
of RBL2H3 that this surface labeling represented, we per-
formed fluorescence immunocytochemistry. Anti-TRPV2
immunoreactivity is present at the cell periphery in a sub-
population (10–20%) of resting RBL2H3 (Fig. 2 F). To-
gether, these data suggest that TRPV2 protein is expressed
in transformed and primary mast cells. Moreover, the con-
figuration and localization of mast cell TRPV2 are consis-
tent with our expectations for a functional channel.
 
Functionally Coupled Responses to Noxious Temperatures in
Mast Cells.
 
TRPV2 activates at 50
 
 
 
C, a temperature that
elicits heat urticaria when used as a diagnostic challenge, in
both endogenous (e.g., mammalian neurons) and overexpres-
sion systems (HEK cells or 
 
Xenopus
 
 oocytes). Prior to the
cloning of TRPV2, heat-induced currents had been described
in sensory neurons, and careful analysis of membrane integrity
in these studies revealed that certain irreversible membrane
events occur only when temperatures of 
 
 
 
59–60
 
 
 
C are at-
tained (45). We assessed cell viability and proliferative capabil-
ity of RBL2H3 and HEK 293 after both ramped and transient
temperature elevation protocols. When peak temperatures
were 
 
 
 
57–58
 
 
 
C, we did not observe detrimental acute effects
on membrane integrity (assayed via Trypan blue exclusion) or
proliferative ability of the cells (unpublished data).
We asked if transient elevation to the TRPV2 threshold
temperature caused secretion of proinflammatory mediators
from RBL2H3 mast cells. Fig. 3 A shows that ligation of the
Fc
 
 
 
RI at 37
 
 
 
C induces serotonin release in RBL2H3 and
that this release depends on the presence of external calcium
during the stimulation period. Similarly, transient elevation
to a peak temperature of 51
 
 
 
C but not 45
 
 
 
C evokes seroto-
nin release that is also dependent on the presence of extracel-
lular calcium. Secretory responses evoked by immunorecep-
tor stimulation and heat transients are both sensitive to the
inhibitor ruthenium red, which has been shown to block
TRPV channels, including TRPV2 (Fig. 3 B; references 21,
46). These data imply that brief elevation to the TRPV2
 
were immunoprecipitated with 2 
 
 
 
g anti-FLAG or 10 
 
 
 
g anti-TRPV2.
Immunocomplexes were resolved by 10% SDS-PAGE and electrotrans-
ferred. FLAG-TRPV2 was visualized by Western blotting in 0.6 
 
 
 
g/ml
anti-FLAG antibody. (D) Native TRPV2 complexes are apparent tetramers
in RBL2H3 cells. Anti-TRPV2 immunocomplexes were purified from
10
 
8
 
 RBL2H3 and resolved by 6–20% gradient Blue-native electrophoresis.
TRPV2 complexes were visualized by anti-TRPV2 Western blot (inset).
Size determination was made relative to a Coomassie-stained gel fragment
containing Apoferritin monomer (242 kD) and dimer (475 kD). Relative
migration graph was plotted using R
 
f
 
 values for apoferritin and recombi-
nant protein standards (250–50-kD range). (E) TRPV2 may be surface
biotinylated in RBL2H3. Intact RBL2H3 (5 
 
 
 
 10
 
7
 
 cells) were surface
biotinylated as described in Materials and Methods. Biotinylation reactions
were quenched with 25 mM NH
 
4
 
Cl. Lysates were immunoprecipitated
with 10 
 
 
 
g anti-TRPV2, and immunocomplexes were resolved by 10%
SDS-PAGE. After electrotransfer, biotinylated proteins were visualized
using Streptavidin-HRP conjugate and ECL. (F) Subcellular localization
of anti-TRPV2 immunofluorescence in RBL2H3. Anti-TRPV2 immu-
nofluorescence in resting RBL2H3 was evaluated as described in Materials
and Methods. Efficacy of the anti-TRPV2 in this application was verified
by dual staining of TRExTRPV2 cells with anti-FLAG and anti-TRPV2
(not depicted). Anti-TRPV2 was used at 0.1 
 
 
 
g/ml and visualized using
an Alexa-488–conjugated anti–mouse secondary antibody. Nuclei were
counter stained with Hoechst 33342 (1 
 
 
 
g/ml). Main panel and inset
show apparent plasma membrane localization of anti-TRPV2 immunore-
activity in a resting RBL2H3 cell.
 
Figure 2 (continued)TRPV2 Expression and Function in Mast Cells 142
Figure 3. (A) Extracellular calcium-dependent degranulation of mast cells after temperature elevation or antigen stimulation. RBL2H3 were cultured
for 24 h in 3H-serotonin. For subsequent Fc RI stimulations, RBL2H3 were primed with 1  g/ml IgE anti-DNP for 16 h. Stimulations were performed
in Tyrode’s buffer (1 mM CaCl2) in the presence or absence of EGTA, as indicated, at 37 C. Fc RI was cross-linked using 100 ng/ml DNP-BSA. Tem-
perature elevations were achieved via application of heated isotonic buffer, and the monitored temperature profiles are shown in the right panel. Serotonin
release was assayed 45 min after stimulation and expressed as a percentage of the maximal signal obtained when RBL2H3 were exposed to a 100 nMStokes et al. 143
threshold temperature initiates a calcium influx pathway that
couples to the degranulation mechanism in mast cells.
Transient temperature elevation causes significant cal-
cium mobilization in RBL2H3. In Fig. 3 C, the tempera-
ture profile and Fura-2 signal were monitored simulta-
neously in RBL2H3 after application of a heated isotonic
buffer. Rapid temperature elevation resulted in a marked
increase in intracellular calcium levels, which declined rap-
idly on cooling (Fig. 3 C). Similar calcium responses were
observed in TRexTRPV2 cells. Responsiveness to TRPV2
threshold temperatures was conferred upon wild-type HEK
cells by TRPV2 transfection, and the magnitude of the
heat-evoked calcium signal correlated positively with the
degree of TRPV2 protein expression (Fig. 3 D). We also
noted a variable degree of sensitivity of these calcium re-
sponses to Ruthenium red and LaCl3 (unpublished data).
We applied ramped temperature increases to RBL2H3
and simultaneously monitored the attained temperature and
Fura-2 fluorescence. Fig. 3 E shows the Fura-2 profile of
multiple individual temperature ramps (n   8) normalized
to the attained temperature. At temperatures between 24
and 33 C, no significant increase in Fura-2 fluorescence is
observed. Through the 34–49 C range, the Fura-2 signal
increases at a mean rate of 0.09 intensity unit  C 1 ( 0.013
U  C 1, n   8). In the 49–54 C range, Fura-2 signal in-
creases at a mean rate of 0.32 intensity unit/ C ( 0.09 U
 C 1, n   8). Thus the rate of calcium increase in these
cells increases significantly (P    0.0001) at two discrete
points in the temperature ramp. The temperature/Fura-2
signal relationship in these cells is therefore consistent with
the sequential opening of multiple channel species that have
distinct threshold temperatures. We asked if such tempera-
ture/Fura-2 signal relationships could detect enhanced ex-
pression of a single channel species. We performed ramped
temperature increases in TRexTRPV2 cells (Fig. 3 F). In
cells with minimal TRPV2 expression, the Fura-2 signal
increases at a rate of 0.0004, 0.004, and 0.007 U C 1 be-
tween the temperatures of 22–38 C, 34–48 C, and 48–
56 C, respectively. In cells with marked overexpression of
TRPV2, the latter rate increases to 0.019 U C 1.
TRPV2 Is a Substrate for PKA-mediated Phosphorylation.
We reasoned that analysis of the protein–protein interactions
made by TRPV2 might give us insight into potential regula-
tory mechanisms that would be applicable to both mast cell
and central nervous system expression contexts for TRPV2.
PKA directly phosphorylates TRPV1 and the heat-sensitive
potassium channel TREK (32, 33, 47), and in both cases,
this phosphorylation modulates the electrophysiological
properties of the channel. We asked if TRPV2 was also a
substrate for regulatory phosphorylation via PKA in mast
cells. We first established that PKA but not PKG could me-
diate the in vitro phosphorylation of TRPV2 (Fig. 4 A).
In vitro phosphorylation assays show that a particular ki-
nase is capable of phosphorylating a substrate such as
TRPV2, but they do not show that this is a physiological
event. We asked if endogenous TRPV2 is a phosphoaccep-
tor. Fig. 4 B shows that the TRPV2 protein that was im-
munoprecipitated from 32Pi-labeled cells shows phosphate
incorporation. In addition, Western blot analysis suggested
that TRPV2 from RBL2H3 cells is recognized by antibod-
ies raised against phospho-threonine (unpublished data) and
by an antibody raised against a phosphorylated PKA sub-
strate motif consensus peptide (Fig. 4 C). Recognition of
TRPV2 by this antibody increases when the cell popula-
tion is exposed to forskolin. Together, these data suggest
that TRPV2 is indeed a PKA substrate and that PKA phos-
PMA, 500 ng/ml ionomycin (n   3). (B) Ruthenium red blocks degranulation of mast cells after temperature elevation or antigen stimulation. Serotonin
release assay was performed as described in Materials and Methods with the addition of 250 nM ruthenium red 5 min before stimulation in the indicated
samples. The maximum attained temperature in this experiment was 52.4 C, and temperature returned to 37 C within 200 s. Black and gray bars show
3H-serotonin levels in extracellular buffer at 30 and 2,700 s after addition of stimuli, respectively. (C) Transient elevation to the TRPV2 threshold tem-
perature causes calcium mobilization in RBL2H3. RBL2H3 were resuspended in Ringer buffer (containing 1 mM CaCl2) at a concentration of 5   106
cells/ml and loaded with 4  M Fura-2 a.m. for 30 min at 37 C. Cells were equilibrated in a 25 C cuvette for the first 40 s recording time. (Heavy trace)
Heated isotonic buffer was applied at 40 s, and the resulting temperature profile is shown in the overlaid broken line. Temperature peaked at 50.1 C and
declined to 27 C during the recording period. (Light trace) Isotonic Ringer buffer (24 C) was added to the cuvette at 40 s and the Fura-2 signal was
recorded over time. (D) Transient elevation to the TRPV2 threshold temperature causes calcium mobilization in TRExTRPV2 cells. TRExTRPV2
cells were incubated in the absence or presence of 1  g/ml tetracycline for 16 h at 37 C. (Left) Relative expression levels of FLAG-TRPV2 in unin-
duced and induced TRExTRPV2 cells. Anti-FLAG immunoprecipitates were harvested from the indicated cells (parental HEK and TRexTRPV2 trans-
fectants) and resolved by 10% SDS-PAGE. Levels of FLAG-TRPV2 were visualized by anti-FLAG Western blot. (Right) Calcium mobilization after
temperature elevation in TRExTRPV2 and HEK cells. Cells were resuspended in Ringer buffer (containing 1 mM CaCl2) at a concentration of 5   106
cells/ml and loaded with 4  M Fura-2 a.m. for 30 min at 37 C. Cells were equilibrated in a 25 C cuvette for the first 40 s recording time. (Black
trace) TRExTRPV2 cells after tetracycline induction. Heated isotonic buffer was applied at 40 s. Maximum attained temperature was 52.8 C. (Blue trace)
TRExTRPV2 cells without tetracycline induction. Heated isotonic buffer was applied at 40 s. Maximum attained temperature was 54.9 C. (Purple trace)
Wild-type HEK cells. Heated isotonic buffer was applied at 40 s. Maximum attained temperature was 53.9 C. (Green trace) TRExTRPV2 cells after tetra-
cycline induction. Isotonic Ringer buffer (24 C) was added to the cuvette at 40 s, and the Fura-2 signal was recorded over time. (E) Relationship between
Fura-2 signal intensity and attained temperature in RBL2H3. RBL2H3 were resuspended in Ringer buffer (containing 1 mM CaCl2) at a concentration
of 5   106 cells/ml and loaded with 4  M Fura-2 a.m. for 30 min at 37 C. The Fura-2 signal and attained temperature were monitored simultaneously
during heat ramps (mean rate of heating, 0.4 Cs 1). The seven individual traces presented here have been normalized to the time course. Shaded area
highlights three distinct phases of calcium mobilization that occur consistently throughout distinct experiments. The following mean ( SD) rates of in-
crease in Fura-2 signal were calculated for seven datasets: 24–33 C, no significant increase in Fura-2 fluorescence is observed; 34–49 C, 0.09 intensity
unit  Cs 1 ( 0.013 U  Cs 1, n   8). In the 49–54 C range, Fura-2 signal increases at a mean rate of 0.32 intensity unit/ C ( 0.09 U  Cs 1, n   8).
(F) Relationship between Fura-2 signal intensity and attained temperature in TRExTRPV2 cells. TRExTRPV2 cells were incubated in the absence or
presence of 1  g/ml tetracycline for 16 h at 37 C (see panel D for expression data). Cells were resuspended in Ringer buffer (containing 1 mM CaCl2) at
a concentration of 5   106 cells/ml and loaded with 4  M Fura-2 a.m. for 30 min at 37 C. The Fura-2 signal and attained temperature were monitored
simultaneously during heat ramps (mean rate of heating 0.31 Cs 1   tet, 0.41 Cs 1   tet).TRPV2 Expression and Function in Mast Cells 144
phorylation of TRPV2 occurs in resting cells but may be
enhanced by cAMP mobilization.
TRPV2 Associates Directly with PKARII in Mast Cells
Via an AKAP. The PKA-mediated phosphorylation of
TRPV2 suggests that the channel is part of a signaling
complex that contains PKA. We detected a protein species
in anti-TRPV2 immunocomplexes that is immunoreactive
with antibodies raised against the PKARII PKAR subunit
(Fig. 5 A).
PKA enzymes rarely associate directly with their sub-
strate. Specific AKAPs are used to target PKA to a particular
substrate (33, 48). A PKA–AKAP signaling module has
been proposed to interact with TRPV1, but the identity of
any TRP-associated AKAP remains unknown (33). We
asked if an AKAP species was likely to mediate the interac-
tion between PKA and TRPV2. We used a cell-permeant
form of the HT31 peptide (35), which is predicted to block
the interaction between AKAPs and PKAR. HT31 exploits
the fact that a conserved secondary structural motif, an am-
phipathic  -helical region, is the contact area between the
known AKAPs and PKAR subunits. Fig. 5 A shows that
HT31 blocks association between TRPV2 and PKARII,
implying that a specific AKAP bridges TRPV2 and PKA.
The PKA-binding Protein ACBD3 May Mediate the
TRPV2–PKA Interaction. The ACBD3 protein (formerly
PAP7) binds PKARI  and apparently recruits PKA to the
peripheral benzodiazepine receptor (34, 49). Our yeast
two-hybrid data (unpublished data) suggested that ACBD3
may bind to the NH2 terminus of TRPVs, and we pro-
posed that ACBD3 might link TRPV2 and the PKAR
subunit. Northern (not depicted) and Western analysis sug-
gests that ACBD3 is widely expressed and is an abundant
protein in the mast cell lines tested here (Fig. 5 B). Fig. 5 C
shows that anti-TRPV2 immunocomplexes from RBL2H3
contain ACBD3. This interaction is unaffected by the HT31
peptide. Fig. 5 D shows that the presence of ACBD3 in
anti-TRPV2 immunoprecipitates is due to the primary im-
munoprecipitation of TRPV2.
We asked if ACBD3 indeed interacted with the PKAR
subunit in RBL2H3. RBL2H3 express both PKARI and
PKARII (not depicted). Fig. 5 E shows that anti-PKARII 
immunoprecipitates purified from RBL2H3 contain ACBD3.
The presence of ACBD3 in PKARII  immunocomplexes
is reduced in cells pretreated with a membrane-permeant
form of the HT31 peptide, indicating an AKAP-like inter-
action. We were not able to capture ACBD3 or PKARI
immunocomplexes from RBL2H3 with the available anti-
bodies, and therefore we cannot assess whether ACBD3 as-
sociates with PKARI .
Discussion
This work describes a novel expression context and reg-
ulatory signaling module for TRPV2. The initial descrip-
tion of TRPV2 (17, 21) suggested a wide distribution of its
transcripts, for example, in leukocytes an observation that
seems inconsistent with a narrow definition of its function
Figure 4. (A) TRPV2 is a substrate for in vitro phosphorylation by
the cAMP-dependent kinase (PKA). TRexTRPV2 cells were treated
with 1  g/ml tetracycline for 16 h. Lysates were immunoprecipitated
with 2  g anti-FLAG or IgGs. Immunocomplexes were resuspended in
a kinase assay buffer with 10  M cAMP/cGMP, 1 U/ l PKA or PKG,
10  M H89, as indicated, and 5  Ci  32P- ATP. Immunocomplexes
were resolved by 10% SDS-PAGE and transferred to PVDF. A dupli-
cate gel was produced for anti-FLAG Western analysis (right). Phos-
phate incorporation into the 90-kD protein doublet corresponding to
TRPV2 (double arrows) was evaluated by exposure to storage phosphor
screens for 4.5 h. Bottom arrow marks position of autophosphorylated
PKA catalytic subunit, whereas autophosphorylated protein kinase G is
apparent at 78 kD (n   3). All lanes in the left panel are derived from
the same gel and are at same contrast. Order of lanes was altered digi-
tally. (B) TRPV2 is a phosphoacceptor. RBL2H3 were metabolically
labeled with 32P-orthophosphate as described in Materials and Methods.
Triton X-100 lysates were prepared from 4   107 cells and immunopre-
cipitated with 10  g anti-TRPV2. Immunocomplexes were resolved by
7.5% SDS-PAGE and transferred to PVDF. The 32P content of anti-
TRPV2 immunocomplexes was assessed by exposure of the membrane
to a storage phosphor screen for 24 h (n   2). (C) TRPV2 recognition
by a phospho-PKA substrate motif antibody increases after forskolin
treatment. RBL2H3 were treated with vehicle or 25  M forskolin for
the 10 min at 37 C. Triton X-100 lysates were prepared from 4   107
cells and immunoprecipitated with 20  g anti-TRPV2. After 10%
SDS-PAGE and electrotransfer, duplicate Western blots were probed
with either anti-TRPV2 (left) or an antibody raised against a phosphor-
ylated consensus PKA substrate motif (right).Stokes et al. 145
as a sensor of pathologically high temperatures. Our current
study supports the concept that TRPV2 protein is not re-
stricted to the central nervous system. In mast cells, at least,
there is the potential for a direct linkage between the
known activation mechanism of TRPV2 and a functional
outcome. We propose that TRPVs, including TRPV2,
may mediate calcium entry in response to physical stimula-
tion of mast cells and that this mechanism is a component
of the signaling pathway that drives inflammatory responses
to physical inputs. The concept of a direct sensor for physi-
cal stimuli in mast cells is supported by previous in vitro
studies, where mast cells were exposed to physical stimuli
in the absence of any local sensory neurons (1, 6–8, 11) and
is suggested by the presence of TRPVs. However, it is also
likely that sensory neurons, also expressing TRPVs, may
contribute indirectly to the control of mast cell activation
in response to physical stimuli, for example, via release of
nerve growth factor, which can induce mast cell activation
(56). The interplay between these mechanisms remains to
be elucidated.
Mast cell TRPVs may contribute to PU where physical
stimuli elicit wheal-flare reactions that are driven by cuta-
neous mast cells. Heat urticaria is evoked diagnostically by
brief exposure of skin to temperatures of 45–55 C, a stimu-
lus that would be predicted to activate the TRPV1 and/or
TRPV2 channels that may be present in cutaneous mast
cells (50). Our data show that these stimuli can be func-
tionally coupled to inflammatory mediator release in a
model mast cell line. Future work may also reveal other
functional linkages between physical stimuli, urticarial re-
sponses, and TRPVs in cutaneous mast cells. For example,
dermatographism is a specific PU where mast cell–depen-
dent wheal-flare reactions follow brief pressure to the der-
mis (9, 10, 14), whereas the diagnostic criterion for cold
urticaria is the appearance of highly localized hives within a
few minutes of cutaneous exposure to temperatures of
4–14 C. Transcripts for the pressure-activated TRPV4 and
a potentially cold-gated TRP channel are present in model
mast cells (unpublished data). Expression of a range of
TRPV-type sensors, if they can be shown to couple to
functionally significant downstream signaling pathways,
may therefore confer sensitivity to a spectrum of physical
stimuli. In addition to the potential for contribution to PU,
it is possible that direct sensing of noxious physical stimuli
by mast cells plays a role in the inflammatory responses that
follow thermal wounding (3, 51).
Figure 5. (A) TRPV2 associates with the PKAR subunit via an AKAP. Triton X-100 lysates were prepared from 5   107 RBL2H3. Lysates were
immunoprecipitated with 10  g anti-TRPV2 in the absence or presence of 50  M HT31 peptide. Immunocomplexes were resolved by 10% SDS-
PAGE and transferred to PVDF. The membrane was sequentially probed with either anti-TRPV2 or the goat polyclonal anti-PKARII (1  g/ml). (B) West-
ern blot analysis of ACBD3 expression. Triton X-100 lysates were prepared from 5   106 cells from the indicated cell lines. Total protein was harvested
from these samples by acetone precipitation, and protein levels were normalized using a Bradford assay. Samples were resolved by 10% SDS-PAGE and
Western blotted using 2  g/ml of the rabbit polyclonal anti-ACBD3. The cell lines tested represent the following backgrounds: P815/RBL2H3, mast;
Ramos, B lymphocyte; jurkat, T lymphocyte; MCF10A/MDAMB435, epithelial fibroblast; PC12, phaeochromocytoma; HT22, neuron; IMR90, fibro-
blast; Cath.a/CAD, neuron. (C) Co-immunoprecipitation of TRPV2 and ACBD3. Triton X-100 lysates were prepared from 5   107 RBL2H3. Lysates
were immunoprecipitated with 10  g anti-TRPV2 in the absence or presence of 50  M HT31 peptide. Immunocomplexes were resolved by 10%
SDS-PAGE and transferred to PVDF. The membrane was divided and probed separately with either anti-TRPV2 or anti-ACBD3 (n   3). (D) Epitope
peptide competition of TRPV2–ACBD3 interaction. Triton X-100 lysates were prepared from 5   107 RBL2H3. Lysates were immunoprecipitated
with 10  g anti-TRPV2 in the absence or presence of 20  g/ml TRPV2 epitope peptide. Immunocomplexes were resolved by 10% SDS-PAGE and
transferred to PVDF. The membrane was divided and probed separately with either anti-TRPV2 or anti-ACBD3 (n   3). (E) Co-immunoprecipitation
of PKARII and ACBD3. Triton X-100 lysates were prepared from 5   107 RBL2H3. Lysates were immunoprecipitated with 10  g of goat polyclonal
anti-PKARII in the absence or presence of 50  M HT31 peptide. Immunocomplexes were resolved by 7.5% SDS-PAGE and transferred to PVDF. The
membrane was probed sequentially with anti-PKARII and anti-ACBD3 (n   3).TRPV2 Expression and Function in Mast Cells 146
Activating stimuli, but not necessarily activation mecha-
nisms, have been described for TRPVs. An activation
mechanism that involves direct physical sensing by the
TRPV is apparently precluded by recent data showing that
excised membrane patches containing TRPV4 do not re-
tain responsiveness to activating temperatures for this chan-
nel (26). It seems likely that a second messenger-based
signaling system is involved, and the diverse apparent regu-
lation of TRPVs by lipid mediators may provide insight
into this issue (17). The presence of a sensitizing mecha-
nism could be important in understanding the role of
TRPv2 in seemingly paradoxical, nonsensory expression
contexts (e.g., lymphocytes). A PKA-mediated sensitization
mechanism has been defined previously for TRPV1 and
the heat-activated K  channel, TREK. Our data suggest
that a PKA signaling module acts directly on TRPV2. Fu-
ture work will reveal which properties of the channel are
affected by PKA phosphorylation. We observe a potentia-
tion in heat-evoked calcium responses in forskolin-treated
RBL2H3, which may reflect A kinase–dependent modula-
tion of TRPV2 channels (unpublished data). However,
there may be considerable complexity in the relationship
between PKA and TRPV2, since we can identify a regu-
lated surface localization step (29, 30) in TRPV2 biosyn-
thesis that is cAMP regulated (unpublished data). There-
fore, forskolin potentiation of TRPV2 responses could be
an effect of increased channel density at the cell surface.
We have identified a novel signaling protein that associ-
ates with TRPV2, the PKAR binding protein ACBD3
(49). This interaction is not exclusive, since ACBD3 has
been described as an adaptor protein in the context of a
mitochondrial complex that is assembled around the volt-
age-dependent anion channel (VDAC) (34, 49). ACBD3
interacts with VDAC via an intermediary protein, the pe-
ripheral benzodiazepine receptor (34, 49). We cannot yet
state whether the TRPV2–ACBD3 interaction is direct. In
both TRPV2 and VDAC contexts, however, it appears
that the role of ACBD3 is to recruit PKA into the channel
microenvironment. ACBD3 appears to fulfill some of the
functional criteria for classification as an AKAP. However,
recruitment of the PKA catalytic subunit by ACBD3 has
not been demonstrated in either system. AKAPs are pro-
posed to contain a common structural motif, an amphi-
pathic a-helix that mediates complex formation between
the AKAP and PKAR subunit. We can identify several
such motifs in the ACBD3 COOH terminus using helical
wheel analysis (not depicted). Future mutational analysis
will determine whether ACBD3 is indeed using this helical
motif to interact with PKAR. It is clear that a PKA signal-
ing module affects the activation properties of TRPV1, ap-
parently contributing to the desensitization process (32,
33). Together with our present data, this observation raises
the question of whether an ACBD3–PKA module is com-
mon to both TRPV1 and TRPV2. To date, we have not
been able to coprecipitate TRPV1 and ACBD3.
In summary, the present study suggests that TRPV cat-
ion channels, including TRPV2, may contribute to mast
cell physiology and potentially to pathologies that result
from inappropriate mast cell activation in response to phys-
ical stimuli. Regulation by cAMP/PKA signaling pathways
may be a recurring theme among TRPV species and may
affect TRPV functionality at multiple levels.
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